Carbohydrate-Based Vaccines pp 145-157 | Cite as
Temporary Conversion of Protein Amino Groups to Azides: A Synthetic Strategy for Glycoconjugate Vaccines
Abstract
Conjugation of synthetic oligosaccharides and native polysaccharides to proteins is an important tool in glycobiology to create vaccines and antigens to screen lectins, toxins, and antibodies. A novel approach to potentiate and profile the immune response to vaccines involves targeting antigens directly to dendritic cells (DCs), the key cells engaged in the immunization process. Inclusion of a carbohydrate ligand recognized by C-type lectins expressed on their cell surface ensures targeting of vaccines to DCs and improved immunological responses. Here we describe a strategy that permits three sequential orthogonal conjugation reactions to prepare glycoconjugates and apply them to the synthesis of a conjugate vaccine that is targeted for uptake by DCs. The carrier protein is treated with an azo-transfer reagent to convert accessible amino groups to azide and then amide bond formation via reaction with carboxylic acid side chains is used to attach amino tether groups of a ligand to the protein. Azide-alkyne Huisgen cycloaddition conjugation, “click chemistry” is used to attach a second ligand equipped with a propargyl group or an analogous terminal alkyne, and following reduction of protein azide groups back to amine, these amino acid side chains can be subjected to amide formation such as reaction with succinimide esters or homobifunctional coupling reagents such as dialkyl squarate.
Key words
Azo transfer Azidination of proteins Protein carrier Oligosaccharide–protein conjugation Click chemistryNotes
Acknowledgement
The research was made possible by grants awarded to D. R. B.; a Discovery grant from the Natural Science and Engineering Research Council of Canada and support from the Alberta Innovates Centers Program.
References
- 1.Lipinski T, Wu X, Sadowska J et al (2012) A trisaccharide conjugate vaccine induces high titer β-mannan specific antibodies that aid clearance of Candida albicans in immunocompromised rabbits. Vaccine 30:6263–6269PubMedCrossRefGoogle Scholar
- 2.Lipinski T, Kitov P, Szpacenko A et al (2011) Synthesis and immunogenicity of a glycopolymer conjugate. Bioconjug Chem 22:274–281PubMedCrossRefGoogle Scholar
- 3.Jiang J, Swiggard WJ, Heufler C et al (1995) The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151–155PubMedCrossRefGoogle Scholar
- 4.Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252PubMedCrossRefGoogle Scholar
- 5.Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419–426PubMedCrossRefGoogle Scholar
- 6.van Kooyk Y, Rabinovich GA (2008) Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol 9:593–601PubMedCrossRefGoogle Scholar
- 7.Geijtenbeek TB, Gringhuis SI (2009) Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9:465–479PubMedCrossRefGoogle Scholar
- 8.Unger WW, van Kooyk Y (2011) “Dressed for Success” C-type lectin receptors for delivery of glyco-vaccines to dendritic cells. Curr Opin Immunol 23:131–137PubMedCrossRefGoogle Scholar
- 9.van Kooyk Y, Unger WW, Fehres CM et al (2013) Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation. Mol Immunol 55:143–145PubMedCrossRefGoogle Scholar
- 10.Fehres CM, Unger WW, Garcia-Vallejo JJ et al (2014) Understanding the biology of antigen cross-presentation for the design of vaccines against cancer. Front Immunol 5:149PubMedCentralPubMedCrossRefGoogle Scholar
- 11.Lipinski T, Fitieh A, St. Pierre J et al (2013) Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to DCs via Dectin-1 by incorporating β-glucan. J Immunol 190:4116–4128PubMedCrossRefGoogle Scholar
- 12.Lönngren J, Goldstein IJ, Niederhuber JE (1976) Aldonate coupling, a simple procedure for the preparation of carbohydrate-protein conjugates for studies of carbohydrate-binding proteins. Arch Biochem Biophys 175:661–669PubMedCrossRefGoogle Scholar
- 13.Svenson SB, Lindberg AA (1979) Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers. J Immunol Methods 25:323–335PubMedCrossRefGoogle Scholar
- 14.Goddard-Borger ED, Stick RV (2007) An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride. Org Lett 9:3797–3800, see also Additions and Corrections to the above paper (2011) Org Lett 13, 2514–2514PubMedCrossRefGoogle Scholar
- 15.Fischer N, Goddard-Borger ED, Greiner R et al (2012) Sensitivities of some imidazole-1-sulfonyl azide salts. J Org Chem 77:1760–1764PubMedCrossRefGoogle Scholar
- 16.Tornoe CW, Christensen C, Meldal M (2002) Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J Org Chem 67:3057–3064PubMedCrossRefGoogle Scholar
- 17.Wang Q, Chan TR, Hilgraf R et al (2003) Bioconjugation by copper (I)-catalyzed azide alkyne [3 + 2] cycloaddition. J Am Chem Soc 125:3192–3193PubMedCrossRefGoogle Scholar
- 18.Wu X, Bundle DR (2005) Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology. J Org Chem 70:7381–7388PubMedCrossRefGoogle Scholar
- 19.Kunishima M, Kawachi C, Iwasaki F et al (1999) Synthesis and characterization of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride. Tetrahedron Lett 40:5327–5330CrossRefGoogle Scholar
- 20.Sen Gupta S, Kuzelka J, Singh P et al (2005) Accelerated bioorthogonal conjugation: a practical method for the Ligation of diverse functional molecules to a polyvalent virus scaffold. Bioconjug Chem 16:1572–1579PubMedCrossRefGoogle Scholar
- 21.Habeeb AFS (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328–336PubMedCrossRefGoogle Scholar